113 related articles for article (PubMed ID: 20145687)
1. Prevalence of Raynaud's phenomenon in the adult New Zealand population.
Purdie G; Harrison A; Purdie D
N Z Med J; 2009 Nov; 122(1306):55-62. PubMed ID: 20145687
[TBL] [Abstract][Full Text] [Related]
2. [The incidence of Raynaud's phenomenon in 1920 residents in Milan].
Gallo E; Bianchi E; Motta A; Piccolo N
Minerva Cardioangiol; 1994; 42(1-2):65-71. PubMed ID: 8022547
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of Raynaud's phenomenon in children ages 12-15 years: prevalence and association with other common symptoms.
Jones GT; Herrick AL; Woodham SE; Baildam EM; Macfarlane GJ; Silman AJ
Arthritis Rheum; 2003 Dec; 48(12):3518-21. PubMed ID: 14674003
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Raynaud's phenomenon.
Bartelink ML; Wollersheim H; van de Lisdonk E; Spruijt R; van Weel C
Neth J Med; 1992 Oct; 41(3-4):149-52. PubMed ID: 1470286
[TBL] [Abstract][Full Text] [Related]
5. Association between Raynaud's phenomenon and migraine in a random population of hospital employees.
O'Keeffe ST; Tsapatsaris NP; Beetham WP
J Rheumatol; 1993 Jul; 20(7):1187-8. PubMed ID: 8371215
[TBL] [Abstract][Full Text] [Related]
6. The self reported prevalence of asthma symptoms amongst adult New Zealanders.
Crane J; Lewis S; Slater T; Crossland L; Robson B; D'Souza W; Pearce N; Town GI; Garrett J; Armstrong R
N Z Med J; 1994 Oct; 107(988):417-21. PubMed ID: 7970336
[TBL] [Abstract][Full Text] [Related]
7. Twelve-month prevalence, severity, and treatment contact of mental disorders in New Zealand born and migrant Pacific participants in Te Rau Hinengaro: The New Zealand Mental Health Survey.
Kokaua J; Schaaf D; Wells JE; Foliaki SA
Pac Health Dialog; 2009 Feb; 15(1):9-17. PubMed ID: 19585730
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Raynaud's phenomenon in a healthy Spanish population.
Riera G; Vilardell M; Vaqué J; Fonollosa V; Bermejo B
J Rheumatol; 1993 Jan; 20(1):66-9. PubMed ID: 8441168
[TBL] [Abstract][Full Text] [Related]
9. Geographical variation in the prevalence of asthma symptoms in New Zealand.
Lewis S; Hales S; Slater T; Pearce N; Crane J; Beasley R
N Z Med J; 1997 Aug; 110(1049):286-9. PubMed ID: 9293281
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for Raynaud's phenomenon in the workforce.
Roquelaure Y; Ha C; Le Manac'h AP; Bodin J; Bodere A; Bosseau C; Descatha A; Leclerc A; Goldberg M; Imbernon E
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):898-904. PubMed ID: 22246858
[TBL] [Abstract][Full Text] [Related]
11. Musculoskeletal pain in the adult New Zealand population: prevalence and impact.
Taylor W
N Z Med J; 2005 Aug; 118(1221):U1629. PubMed ID: 16138167
[TBL] [Abstract][Full Text] [Related]
12. Raynaud's phenomenon: clinical spectrum of 118 patients.
De Angelis R; Del Medico P; Blasetti P; Cervini C
Clin Rheumatol; 2003 Oct; 22(4-5):279-84. PubMed ID: 14576990
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of cryptosporidiosis in New Zealand, 1997-2006.
Snel SJ; Baker MG; Venugopal K
N Z Med J; 2009 Feb; 122(1290):47-61. PubMed ID: 19319168
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric illness among a nationally representative sample of sole and partnered parents in New Zealand.
Tobias M; Gerritsen S; Kokaua J; Templeton R
Aust N Z J Psychiatry; 2009 Feb; 43(2):136-44. PubMed ID: 19153921
[TBL] [Abstract][Full Text] [Related]
15. Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison.
Maricq HR; Carpentier PH; Weinrich MC; Keil JE; Palesch Y; Biro C; Vionnet-Fuasset M; Jiguet M; Valter I
J Rheumatol; 1997 May; 24(5):879-89. PubMed ID: 9150076
[TBL] [Abstract][Full Text] [Related]
16. Initial prevalence and incidence of secondary Raynaud's phenomenon in patients with Raynaud's symptomatology.
Hirschl M; Kundi M
J Rheumatol; 1996 Feb; 23(2):302-9. PubMed ID: 8882036
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Raynaud's phenomenon in 2 ethnic groups in the general population of Estonia.
Valter I; Maricq HR
J Rheumatol; 1998 Apr; 25(4):697-702. PubMed ID: 9558171
[TBL] [Abstract][Full Text] [Related]
18. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
[TBL] [Abstract][Full Text] [Related]
19. Color chart assisted diagnosis of Raynaud's phenomenon in an unselected hospital employee population.
O'Keeffe ST; Tsapatsaris NP; Beetham WP
J Rheumatol; 1992 Sep; 19(9):1415-7. PubMed ID: 1433009
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for asthma symptoms in Kawerau children.
Shaw R; Woodman K; Crane J; Moyes C; Kennedy J; Pearce N
N Z Med J; 1994 Oct; 107(987):387-91. PubMed ID: 7936475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
